A.Y. Chang et al, “The Hypoglycemic Effect of Ciglitazone in Obese, Hyperglycemic Animal Models”, Prog. Clin. Biol. Res., pp. 177-192 (1988). |
T. Sohda et al, “Studies on Antidiabetic Agents. II. Synthesis of 5-[4(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and Its Derivatives”, Chem. Phar. Bull., vol. 30(10), pp. 3580-3600 (1982). |
T. Fujiwara et al, “Characterization of New Oral Antidiabetic Agent CS-045”, Diabetes, vol. 37(11), pp. 1549-1558 (Nov. 1988). |
T. Sohda et al, “Studies on Antidiabetic Agents”, Arzneim.-Forsch./Drug Res., vol. 40(I), Nr. 1, pp. 37-42 (1990). |
J.R. Colca et al, “Pioglitazone Hydrochloride Inhibits Cholesterol Absorption and Lowers Plasma Cholesterol Concentrations in Cholesterol-Fed Rats”, Diabetes, vol. 40(12), pp. 1669-1674 (Dec. 1991). |
A.K. Saha et al, “Lipid Abnormalities in Tissues of the KKAy Mouse: Effects of Pioglitazone on Malonyl-CoA and Diacylglycerol”, The American Physiological Society, vol. 267, pp. E95-E101 (1994). |
N.D. Oakes et al, “A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat”, Diabetes, vol. 43(10), pp. 1203-1210 (Oct. 1994). |
H. Ikeda et al, “Effects of Pioglitazone on Glucose and Lipid Metabolism in Normal and Insulin Resistant Animals”, Arzneim.-Forsch./Drug Res., vol. 40(I), Nr. 2, pp. 156-162 (1990). |
L. Bowen et al, “The Effect of CP 68,722, a Thiozolidinedione Derivative, on Insulin Sensitivity in Lean and Obese Zuker Rats” Metabolism, vol. 40, No. 10, pp. 1025-1030 (Oct. 1991). |
J.W. Kemnitz et al, “Pioglitazone Increases Insulin Sensitivity, Reduces Blood Glucose, Insulin, and Lipid Levels, and Lowers Blood Pressure in Obese, Insulin-Resistant Rhesus Monkeys”, Diabetes, vol. 43(2), pp. 204-211 (Feb. 1994). |
H. Keen, “Insulin Resistance and the Prevention of Diabetes Mellitus”, The New England Journal of Medicine, vol. 331, No. 18, pp. 1226-1227 (Nov. 1994). |
S. Yoshioka et al, “Antihypertensive Effects of CS-045 Treatment in Obese Zucker Rats”, Metabolism, vol. 42, No. 1, pp. 75-80 (Jan. 1993). |
R.K. Dubey et al, “Pioglitazone Attenuates Hypertension and Inhibits Growth of Renal Arteriolar Smooth Muscle in Rats”, The American Physiological Society, vol. 265, pp. R726-R732 (1993). |
F. Zhang et al, “Effects of Pioglitazone on Calcium Channels in Vascular Smooth Muscle”, Hypertension, vol. 24(2), pp. 170-175 (1994). |
J. Ohsumi et al, “Troglitazone Prevents the Inhibitory Effects of Inflammatory Cytokines on Insulin-Induced Adipocyte Differentiation in 3T3-L1 Cells”, Endocrinology, vol. 135, No. 5, pp. 2279-2282 (1994). |
D. Szalkowski et al, “Antidiabetic Thiazolidinediones Block the Inhibitory Effect of Tumor Necrosis Factor-α on Differentiation, Insulin-Stimulated Glucose Uptake, and Gene Expression in 3T3-L1 Cells”, Endocrinology, vol. 136, No. 4, pp. 1474-1481 (1995). |